Skip to content

Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis

Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03006783
Enrollment
50
Registered
2016-12-30
Start date
2016-03-31
Completion date
2016-10-31
Last updated
2016-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Palsy

Brief summary

A retrospective and cross-sectional analysis of standard of care for facial paralysis involving the cross-face nerve graft in the past 20 years. * Imagery analysis * Questionnaires

Detailed description

The investigators will retrospectively and cross sectionally analyze all patients treated with a cross-face nerve graft and another nerve transfer in our institution by image analysis and sending out quality of life questionnaires.

Interventions

PROCEDURECross-face nerve graft

connecting the healthy facial nerve to the affected facial nerve

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Treated with one of the described procedures

Exclusion criteria

* Evaluation material present

Design outcomes

Primary

MeasureTime frameDescription
Symmetry of the mouthMarch 2016 - October 2016Symmetry of the mouth expressed as the difference in millimeters between the position of the affected and the healthy corner of the mouth on a picture. An ideal symmetry would be 0 mm. Measured with the FACE-gram software.
Excursion of the mouthMarch 2016 - October 2016Excursion of the mouth expressed as the difference in millimeters between the position of the affected corner of the mouth in repose and with smile on a picture. Measured with the FACE-gram software.
Disease-specific quality-of-lifeMarch 2016 - October 2016A validated self-reported disease-specific quality-of-life questionnaire was used (Facial Clinimetric Evaluation scale). On which patients can score anything between 0 and 100 points (100 being healty).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026